Nanotherapeutics is a product of the Sid Martin Biotechnology Incubator of Alachua, Florida [REF].
At the end of 2014, Baxter indicated its intention to sell a vaccine production technology based on Vero cell culture to Nanotherapeutics; this was to include developed vaccines for H5N1, H1N1 and seasonal influenza, as well as a number of investigational vaccine programs [REF].